Detonating fuse for breast cancer discovered

(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) Targeted treatment of basal-like breast cancer could be facilitated by YAP inhibitors in the future. As reported by an MDC team headed by Walter Birchmeier in the scientific journal Cancer Research, this type of cancer requires the support of the YAP protein to stimulate the growth of cancer stem cells.